Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data.

Riches, Nicholas; Vinikoor, Michael; Guingane, Alice; Johannessen, Asgeir; Lemoine, Maud; Matthews, Philippa; Okeke, Edith; Shimakawa, Yusuke; Sombie, Roger; Stockdale, Alexander; Wandeler, Gilles; Andersson, Monique; Davwar, Pantong; Desalegn, Hailemichael; Duguru, Mary; Fall, Fatou; Maponga, Tongai; Nyam Paul, David; Seydi, Moussa; Sinkala, Edford; ... (2023). Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data. Epidemiology and infection, 151, e65. Cambridge University Press 10.1017/S095026882300050X

[img]
Preview
Text
Riches_EpidemiolInfect_2023.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (821kB) | Preview

Approximately 80 million people live with chronic hepatitis B virus (HBV) infection in the WHO Africa Region. The natural history of HBV infection in this population is poorly characterised, and may differ from patterns observed elsewhere due to differences in prevailing genotypes, environmental exposures, co-infections, and host genetics. Existing research is largely drawn from small, single-centre cohorts, with limited follow-up time. The Hepatitis B in Africa Collaborative Network (HEPSANET) was established in 2022 to harmonise the process of ongoing data collection, analysis, and dissemination from 13 collaborating HBV cohorts in eight African countries. Research priorities for the next 5 years were agreed upon through a modified Delphi survey prior to baseline data analysis being conducted. Baseline data on 4,173 participants with chronic HBV mono-infection were collected, of whom 38.3% were women and the median age was 34 years (interquartile range 28-42). In total, 81.3% of cases were identified through testing of asymptomatic individuals. HBeAg-positivity was seen in 9.6% of participants. Follow-up of HEPSANET participants will generate evidence to improve the diagnosis and management of HBV in this region.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Wandeler, Gilles

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0950-2688

Publisher:

Cambridge University Press

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

12 Jul 2023 16:37

Last Modified:

20 Jul 2023 08:25

Publisher DOI:

10.1017/S095026882300050X

PubMed ID:

37009881

Uncontrolled Keywords:

Africa Epidemiology antiviral agents hepatitis B hepatocellular carcinoma liver cirrhosis

BORIS DOI:

10.48350/184724

URI:

https://boris.unibe.ch/id/eprint/184724

Actions (login required)

Edit item Edit item
Provide Feedback